Welcome to the international HTA database

Showing [23371 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Routine dental care programs in long term care: a review of the clinical effectiveness and guidelines
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Costing methods in healthcare]
2012	Norwegian Knowledge Centre for the Health Services (NOKC)	[Prevention of allergy among children]
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Hydroxocobalamin for cyanide poisoning in the pre-hospital setting: a review of the comparative clinical effectiveness and safety
2012	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[1st Expert Panel on viper venomous bite in Spain]
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Research on medical care utilization of stroke patients and related factors in Korea]
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Denosumab and zoledronic acid for patients with postmenopausal osteoporosis: a review of the clinical effectiveness, safety, cost effectiveness, and guidelines
2012	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Impact of day care centres in monitoring patients with Obstructive Sleep Apnea Syndrome (OSAS)]
2012	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Economic evaluation of the introduction of the HPV vaccine in Spain to prevent cervical cancer]
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[A study on Korean adolescents' risk factors of suicide]
2012	NIHR Health Technology Assessment programme	Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Telemetry devices to monitor cardiac patients: a review of the safety and guidelines
2012	Health Information and Quality Authority (HIQA)	Health technology assessment of a national deep brain stimulation service in Ireland
2012	HAYES, Inc.	Pulmonary thromboendarterectomy for treatment of pulmonary hypertension
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Risk factors at the regional level for suicide in the Korean elderly]
2012	Agency for Healthcare Research and Quality (AHRQ)	Noninvasive technologies for the diagnosis of coronary artery disease in women
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Cannabinoids for the treatment of post-traumatic stress disorder: a review of the clinical effectiveness and guidelines
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[HIV screening in the general population]
2012	HAYES, Inc.	Qsymia (phentermine/topiramate; Vivus Inc.) for obesity management
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	Asian study on the value for a QALY: Korean results
2012	Norwegian Knowledge Centre for the Health Services (NOKC)	[The effectiveness of health promotion and preventive interventions on nutrition, physical activity, obesity, and sexual health in children and adolescents]
2012	HAYES, Inc.	Stereotaxis niobe magnetic navigation system (Stereotaxis Inc.) for percutaneous coronary intervention in coronary artery disease
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Infliximab versus methotrexate, etanercept, adalimumab, and ustekinumab for plaque psoriasis: a review of the comparative clinical efficacy, safety and cost effectiveness
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Screening for colorectal cancer part 1: screening-tests and program design
2012	HAYES, Inc.	Relieva balloon sinuplasty (Acclarent Inc.) for chronic sinusitis in adults
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Diagnostic accuracy of anti-CCP antibody test in rheumatoid arthritis: systematic review]
2012	Norwegian Knowledge Centre for the Health Services (NOKC)	[List size and quality of care among GPs within The Regular General Practitioner Scheme]
2012	Medical Services Advisory Committee (MSAC)	Testing for HER-2 status in advanced or metastatic breast cancer (stage IIIA-IV) to access lapatinib
2012	Agency for Healthcare Research and Quality (AHRQ)	Registry of patient registries (RoPR): policies and procedures
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Sterile pre-filled saline syringes for acute care patients: a review of clinical evidence, cost-effectiveness, evidence-based guidelines, and safety
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Lenalidomide (Revlimid®) for the first-line therapy of transplant-ineligible patients with multiple myeloma
2012	HAYES, Inc.	Relieva balloon sinuplasty (Acclarent Inc.) for chronic sinusitis in children
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Polysomnography in the diagnosis of sleep-related breathing disorders]
2012	Norwegian Knowledge Centre for the Health Services (NOKC)	[Effects of organisational interventions for mental health services]
2012	Agency for Healthcare Research and Quality (AHRQ)	Treatment for glaucoma: comparative effectiveness
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Modafinil for sleep disorders and fatigue secondary to multiple sclerosis: a review of the clinical efficacy and safety
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Evidence overview of therapeutic hypothermia]
2012	HAYES, Inc.	Sacroiliac joint fusion for the treatment of adult low back pain
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Efficacy of atomoxetine and methylphenidate in attention deficits hyperactivity disorder in adults: a rapid review]
2012	Norwegian Knowledge Centre for the Health Services (NOKC)	[Effects of organised follow-up of behaviour that may increase risk of disease in adults]
2012	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Examination and treatment of older people after a fall – a health technology assessment]
2012	Medical Services Advisory Committee (MSAC)	Holmium Laser Enucleation of the Prostate (HOLEP) combined with tissue morcellation
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Subcutaneous immunotherapy for the treatment of allergies: a review of the clinical efficacy, safety and guidelines
2012	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Researchers' perceptions about the clinical and health services research call]
2012	HAYES, Inc.	Selenia dimensions digital tomosynthesis system (Hologic Inc.) for diagnostic mammography
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[A systematic review of the diagnostic accuracy of FDG PET/PET-CT for fever of unknown origin]
2012	Norwegian Knowledge Centre for the Health Services (NOKC)	[Effects of support and follow-up interventions for people with severe mental illness]
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Electrocardiograms versus x-rays for guided placement of central venous catheter tips: a review of clinical and cost-effectiveness
2012	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Catalan arthroplasty register. 2nd report (data 2005-2010)]
2012	HAYES, Inc.	Seprafilm adhesion barrier (Genzyme Corp.) for prevention of abdominal adhesions after general abdominal surgery
2012	Norwegian Knowledge Centre for the Health Services (NOKC)	[The effectiveness of primary interventions to prevent the use of tobacco, alcohol and other drugs among children and adolescents]
2012	Agency for Healthcare Research and Quality (AHRQ)	Management of asymptomatic carotid stenosis
2012	HAYES, Inc.	Xoft Axxent eBx electronic brachytherapy system (iCAD Inc.) for early-stage breast cancer
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Sodium chloride inhalation for the treatment of cystic fibrosis: a review of the clinical evidence, cost-effectiveness and guidelines
2012	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Pharmacological treatment for controlled ovarian hyperstimulation in vitro fertilization]
2012	HAYES, Inc.	Seprafilm adhesion barrier (Genzyme Corp.) for prevention of abdominal adhesions after gynecologic surgery
2012	HAYES, Inc.	Accelerated partial breast irradiation for breast cancer using conformal and intensity-modulated radiation therapy
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Drug eluting stents in adults with acute coronary syndrome: a review of the clinical effectiveness, safety and guidelines
2012	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Non-traumatic neck pain: appropriateness use of diagnostic imaging tests]
2012	HAYES, Inc.	SNaP wound care system (Spiracur Inc.) for treatment of lower extremity ulcers
2012	HAYES, Inc.	Antibiotic-coated sutures
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Non-alcohol hand sanitizers for non-healthcare personnel: a review of the clinical effectiveness and guidelines
2012	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Idebenone for the treatment of Friedreich's ataxia]
2012	HAYES, Inc.	Solesta (Q-Med AB) for treatment of fecal incontinence
2012	Agency for Healthcare Research and Quality (AHRQ)	The impact of pre-transplant red blood cell transfusions in renal allograph rejection
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Adaptive servo ventilation versus continuous or bi-level positive airway pressure: a review of the clinical effectiveness, cost-effectiveness and guidelines
2012	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Priorization for patients on waiting lists: development of a generic system]
2012	HAYES, Inc.	Somatosensory evoked potentials (SEPs) for intraoperative monitoring during spinal cord surgery for trauma or tumors
2012	Basque Office for Health Technology Assessment (OSTEBA)	[Assistance at normal childbirth. Guide for pregnant women, future parents, as well as their partners and relatives]
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Electronic cigarettes: a review of the clinical evidence and safety
2012	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Digital hearing aid in comparison with analog hearing aid for presbycusis: evaluation of the clinical effectiveness and the cost-effectiveness]
2012	HAYES, Inc.	Sphincter pharyngoplasty for velopharyngeal insufficiency in children
2012	Basque Office for Health Technology Assessment (OSTEBA)	[Clinical practice guideline on type 1 diabetes]
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Therapy dogs and horses for mental health: a review of the clinical effectiveness
2012	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Clinical practice guideline of care for people with multiple sclerosis]
2012	HAYES, Inc.	Subcutaneous implantation of estradiol pellets for postmenopausal disorders
2012	Basque Office for Health Technology Assessment (OSTEBA)	[They just told me I have diabetes! Guide for youth and adults with type 1 diabetes and in intensive treatment]
2012	Medical Advisory Secretariat (MAS)	Chronic Obstructive Pulmonary Disease (COPD)
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Drug eluting stents in adults with in-stent restenosis: a review of the clinical effectiveness, safety and guidelines
2012	Andalusian Health Technology Assessment Area (AETSA)	[Safety and effectiveness of oncolytic viruses in advanced cancer. systematic review of the literature]
2012	HAYES, Inc.	Transarterial hepatic yttrium-90 radioembolization for treatment of unresectable intrahepatic cholangiocarcinoma
2012	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Bone graft substitutes in traumatology]
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Lymphocyte transformation testing (LTT) or lymphocyte proliferation testing (LPT) for hip or knee arthroplasty: a review of clinical and cost-effectiveness, and evidence-based guidelines
2012	HAYES, Inc.	VersaJet II hydrosurgery system (Smith & Nephew Inc.) for treatment of burns
2012	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Falls prevention for the elderly]
2012	Agency for Healthcare Research and Quality (AHRQ)	Enabling patient-centered care through health information technology (Health IT)
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Tiotropium compared with ipratropium for patients with moderate to severe chronic obstructive pulmonary disease: a review of the clinical effectiveness
2012	Andalusian Health Technology Assessment Area (AETSA)	[Extended neonatal screening for lysosomal diseases by mass spectrometry]
2012	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Evaluation of acellular dermal matrix for breast reconstruction: an update
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Dual antiplatelet therapy and enoxaparin or unfractionated heparin for patients with ST-elevation myocardial infarction: a review of the clinical evidence
2012	HAYES, Inc.	X stop interspinous process decompression system (Medtronic Spine LLC) for lumbar spinal stenosis
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	A systematic review of intravitreal bevacizumab for the treatment of diabetic macular edema
2012	Andalusian Health Technology Assessment Area (AETSA)	[New oral anticoagulants for the prevention of stroke and systemic embolism in non-valvular atrial fibrillation]
2012	HAYES, Inc.	Breast cancer susceptibility 1 and 2 (BRCA1/2) gene testing for hereditary breast and ovarian cancer (HBOC)
2012	HTA Unit, University of Calgary	A health technology assessment of transient elastography in liver disease
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Denosumab, raloxifene, and zoledronic acid for the treatment of postmenopausal osteoporosis: clinical effectiveness and harms
2012	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Insulin detemir (Levemir®) 100 U/ml solution for injection
2012	Technology Assessment Unit of the McGill University Health Centre (MUHC)	The hybrid operating room. Should one be available for cardiovascular-thoracic procedures in the MUHC? A brief report
2012	Penn Medicine Center for Evidence-based Practice (CEP)	Reducing pneumonia readmissions
2012	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Fidaxomicin (Dificlir®) 200 mg film-coated tablets